Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cocaine vs Lidocaine/Xylometazoline for Intranasal Analgesia
NCT06443255Phase 3Completed
- Sponsor
- Rigshospitalet
- Start
- Jul 2024
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lidocaine, xylometazoline in procedural pain, sponsored by Rigshospitalet. Started Jul 2024; status: completed.
02
Drugs
lidocainexylometazoline
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT06443255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06443255.